1. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016; 315:801–10.
Article
2. Bellomo R, Kellum JA, Ronco C, Wald R, Martensson J, Maiden M, et al. Acute kidney injury in sepsis. Intensive Care Med. 2017; 43:816–28.
Article
3. Ronco C, Bellomo R, Kellum JA. Acute kidney injury. Lancet. 2019; 394:1949–64.
Article
4. Rangaswami J, Bhalla V, Blair JEA, Chang TI, Costa S, Lentine KL, et al. Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. Circulation. 2019; 139:e840–78.
Article
5. Lee SA, Cozzi M, Bush EL, Rabb H. Distant organ dysfunction in acute kidney injury: a review. Am J Kidney Dis. 2018; 72:846–56.
Article
6. Poston JT, Koyner JL. Sepsis associated acute kidney injury. BMJ. 2019; 364:k4891.
Article
7. Kellum JA, Bellomo R, Ronco C. Progress in prevention and treatment of acute kidney injury: moving beyond kidney attack. JAMA. 2018; 320:437–8.
8. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012; 2:1–141.
9. Palevsky PM, Liu KD, Brophy PD, Chawla LS, Parikh CR, Thakar CV, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. Am J Kidney Dis. 2013; 61:649–72.
Article
10. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996; 22:707–10.
11. Joannidis M, Forni LG. Clinical review: timing of renal replacement therapy. Crit Care. 2011; 15:223.
Article
12. Ernst A, Köhrle J, Bergmann A. Proenkephalin A 119–159, a stable proenkephalin A precursor fragment identified in human circulation. Peptides. 2006; 27:1835–40.
Article
13. Beunders R, Struck J, Wu AHB, Zarbock A, Di Somma S, Mehta RL, et al. Proenkephalin (PENK) as a novel biomarker for kidney function. J Appl Lab Med. 2017; 2:400–12.
Article
14. Beunders R, van Groenendael R, Leijte G, Kox M, Pickkers P. Proenkephalin compared to conventional methods to assess kidney function in critically ill sepsis patients. Shock. 2020; Jan. 21. DOI:
10.1097/SHK.0000000000001510.
Article
15. Marino R, Struck J, Hartmann O, Maisel AS, Rehfeldt M, Magrini L, et al. Diagnostic and short-term prognostic utility of plasma pro-enkephalin (pro-ENK) for acute kidney injury in patients admitted with sepsis in the emergency department. J Nephrol. 2015; 28:717–24.
Article
16. Kim H, Hur M, Lee S, Marino R, Magrini L, Cardelli P, et al. Proenkephalin, neutrophil gelatinase-associated lipocalin, and estimated glomerular filtration rates in patients with sepsis. Ann Lab Med. 2017; 37:388–97.
Article
17. Caironi P, Latini R, Struck J, Hartmann O, Bergmann A, Bellato V, et al. Circulating proenkephalin, acute kidney injury, and its improvement in patients with severe sepsis or shock. Clin Chem. 2018; 64:1361–9.
Article
18. Hollinger A, Wittebole X, François B, Pickkers P, Antonelli M, Gayat E, et al. Proenkephalin A 119–159 (Penkid) is an early biomarker of septic acute kidney injury: the Kidney in Sepsis and Septic Shock (Kid-SSS) Study. Kidney Int Rep. 2018; 3:1424–33.
Article
19. Moledina DG. Penkid: a novel biomarker of reduced GFR in sepsis. Kidney Int Rep. 2018; 4:17–9.
Article
20. Shah KS, Taub P, Patel M, Rehfeldt M, Struck J, Clopton P, et al. Proenkephalin predicts acute kidney injury in cardiac surgery patients. Clin Nephrol. 2015; 83:29–35.
Article
21. Emmens JE, Ter Maaten JM, Damman K, van Veldhuisen DJ, de Boer RA, Struck J, et al. Proenkephalin, an opioid system surrogate, as a novel comprehensive renal marker in heart failure. Circ Heart Fail. 2019; 12:e005544.
Article
22. Kanagala P, Squire IB, Jones DJL, Cao TH, Chan DCS, McCann G, et al. Proenkephalin and prognosis in heart failure with preserved ejection fraction: a GREAT network study. Clin Res Cardiol. 2019; 108:940–9.
Article
23. Donato LJ, Meeusen JW, Lieske JC, Bergmann D, Sparwaßer A, Jaffe AS. Analytical performance of an immunoassay to measure proenkephalin. Clin Biochem. 2018; 58:72–7.
Article
24. Wu AHB, Anand I. The biological variation of plasma proenkephalin: data from a stable heart failure cohort. Clin Chem Lab Med. 2019; 57:e105–7.
Article
25. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009; 150:604–12.
Article
26. Cole TJ. Too many digits: the presentation of numerical data. Arch Dis Child. 2015; 100:608–9.
Article
27. Legrand M, Hollinger A, Vieillard-Baron A, Dépret F, Cariou A, Deye N, et al. One-year prognosis of kidney injury at discharge from the ICU: a multicenter observational study. Crit Care Med. 2019; 47:e953–61.
28. Rosenqvist M, Bronton K, Hartmann O, Bergmann A, Struck J, Melander O. Proenkephalin a 119–159 (penKid)–a novel biomarker for acute kidney injury in sepsis: an observational study. BMC Emerg Med. 2019; 19:75.
29. Thomas ME, Blaine C, Dawnay A, Devonald MA, Ftouh S, Laing C, et al. The definition of acute kidney injury and its use in practice. Kidney Int. 2015; 87:62–73.
Article